French Pharmaceuticals & Biotech Potentially Undervalued Companies

Sanofi

Market Cap: €91.4b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Vetoquinol

Market Cap: €831.0m

A veterinary pharmaceutical company, engages in designing, developing, and selling of veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region.

Virbac

Market Cap: €2.8b

Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific.

Oncodesign Société Anonyme

Market Cap: €99.4m

Oncodesign Société Anonyme, a biopharmaceutical company, conducts research and development work on new therapeutic and diagnostic tools with pharmaceutical firms, biotech companies, public research institutions, and investment groups.

Cellectis

Market Cap: €188.2m

A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications.

Eurofins Scientific

Market Cap: €11.5b

Provides various analytical testing and laboratory services worldwide.

Poxel

Market Cap: €10.8m

A clinical-stage biopharmaceutical company, develops novel treatments for metabolic pathophysiology, type 2 diabetes, and liver diseases.

Boiron

Market Cap: €474.0m

Manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally.

Euroapi

Market Cap: €117.1m

Develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally.

Genfit

Market Cap: €672.3m

Engages in the research and development of medicines and diagnostic solutions in France and internationally.

Novacyt

Market Cap: €32.3m

Develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmental sectors.

DBV Technologies

Market Cap: €704.3m

A clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France.

Sartorius Stedim Biotech

Market Cap: €16.3b

Engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.

MedinCell

Market Cap: €933.5m

A clinical-stage and commercial biopharmaceutical licensing company, develops long acting injectables in various therapeutic areas in France.